Edap TMS (Edap TMS) Change In Receivables

: $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

Edap TMS's change in receivables for the quarter that ended in Dec. 2023 was $0.00 Mil. It means Edap TMS's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Edap TMS's change in receivables for the fiscal year that ended in Dec. 2023 was $-5.35 Mil. It means Edap TMS's Accounts Receivable increased by $5.35 Mil from Dec. 2022 to Dec. 2023 .

Edap TMS's Accounts Receivable for the quarter that ended in Dec. 2023 was $18.74 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Edap TMS's Days Sales Outstanding for the three months ended in Dec. 2023 was 79.96.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Edap TMS's liquidation value for the three months ended in Dec. 2023 was $31.94 Mil.

Edap TMS Change In Receivables Historical Data

The historical data trend for Edap TMS's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edap TMS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

1.01

1.38

-0.12

-2.09

-5.35

Edap TMS Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables																-	-	-	-	-

Edap TMS Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Edap TMS (NAS:EDAP) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Edap TMS's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	18.742	/	21.388	*	91
=	79.96

2. In Ben Graham's calculation of liquidation value, Edap TMS's accounts receivable are only considered to be worth 75% of book value:

Edap TMS's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	47.406	-	37.759	+	0.75 * 18.742	+	0.5 * 16.48
=	31.94

Edap TMS Change In Receivables Related Terms

Thank you for viewing the detailed overview of Edap TMS's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Edap TMS (Edap TMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Edap TMS SA (NAS:EDAP) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

EDA:Germany

Address

Parc d'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120

Website

https://www.edap-tms.com

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.